Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Eletriptan for acute migraine headaches in adults.

Literature DB >> 25267910

Eletriptan for acute migraine headaches in adults.

Sheena Derry¹, R Andrew Moore¹, Henry J McQuay¹.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of eletriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Entities: CellLine Chemical Disease Gene Species

Year: 2010 PMID： 25267910 PMCID： PMC4176626 DOI： 10.1002/14651858.CD008490

Source DB: PubMed Journal: Cochrane Database Syst Rev ISSN： 1361-6137

26 in total

1. The International Classification of Headache Disorders: 2nd edition.

Authors:
Journal: Cephalalgia Date: 2004 Impact factor: 6.292

2. Impact of covert duplicate publication on meta-analysis: a case study.

Authors: M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal: BMJ Date: 1997-09-13

Review 3. Burden of migraine. A review of its socioeconomic impact.

Authors: G D Solomon; K L Price
Journal: Pharmacoeconomics Date: 1997 Impact factor: 4.981

4. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

Authors: J H Lofland; N E Johnson; A S Batenhorst; D B Nash
Journal: Arch Intern Med Date: 1999-04-26

5. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Authors: Seymour Diamond; Marcelo E Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B Lipton
Journal: Headache Date: 2007-03 Impact factor: 5.887

Review 1. Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response.

Authors: Matilde Capi; Martina Curto; Luana Lionetto; Fernando de Andrés; Giovanna Gentile; Andrea Negro; Paolo Martelletti
Journal: Ther Adv Neurol Disord Date: 2016-06-03 Impact factor: 6.570

1 in total

Eletriptan for acute migraine headaches in adults.

1. The International Classification of Headache Disorders: 2nd edition.

2. Impact of covert duplicate publication on meta-analysis: a case study.

Review 3. Burden of migraine. A review of its socioeconomic impact.

4. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

5. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

6. The number needed to treat: a clinically useful measure of treatment effect.

7. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

8. Prevalence and burden of headache and migraine in Germany.

9. Improvements in health-related quality of life with sumatriptan treatment for migraine.

10. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Review 1. Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response.